Activation of matrix metalloproteinases (MMP2 and MMP9) was shown to be involved in the pathogenesis of SD following exposure to monocrotaline (a pyrrolizidine alkaloid) [36] and oxaliplatin [34]. Here, MMP2 is linked to Salla disease.